FDA Drug Application (015103) for DEMI-REGROTON by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number015103
Product Number002
FormTABLET;ORAL
Dosage25MG;0.125MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDEMI-REGROTON
Active IngredientCHLORTHALIDONE; RESERPINE



Back to FDA Applications sponsored by SANOFI AVENTIS US

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.